Author:
Silverman Daniel H.S.,Lau Victoria,Geist Cheri,Siu Erin
Reference29 articles.
1. 1. Silverman DHS, Small GW, Chang CY,. Positron emission tomography in evaluation of dementia. JAMA 2001;286:2120–2127.
2. 2. Herholz K, Nordberg A, Salmon E,. Impairment of neocortical metabolism predicts progression in AD. Dement Geriatr Cogn Disord 1999;10:494–504.
3. 3. Silverman DHS, Truong CT, Kim SK,. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Molec Genet Metab 2003;80:350–355.
4. 4. Hoffman JM, Welsh-Bohmer KA, Hanson M,. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med 2000;41:1920–1928.
5. 5. Silverman DHS. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med 2004;45:594–606.